Case Report: AL Amyloidosis Severe Restrictive Cardiomyopathy Associated With Multiple Myeloma—Diagnostic Difficulties

BACKGROUND: Cardiac AL amyloidosis as a complication of multiple myeloma (MM) is a formidable life-threatening condition. The first-line therapy for both MM and systemic AL amyloidosis is proteasome inhibitors (PIs). Unfortunately, the use of PIs may lead to cardiovascular toxicity development, whic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirichenko, Yulia Y., Ilgisonis, Irina S., Nakhodnova, Elena S., Sokolova, Irina Y., Bochkarnikova, Olga V., Kardanova, Sabina A., Lyapidevskaya, Olga V., Privalova, Elena V., Ershov, Vladimir I., Belenkov, Yurii N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235537/
https://www.ncbi.nlm.nih.gov/pubmed/35770217
http://dx.doi.org/10.3389/fcvm.2022.862409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235537/
https://www.ncbi.nlm.nih.gov/pubmed/35770217
http://dx.doi.org/10.3389/fcvm.2022.862409

Ejemplares similares